Skip to main content
Signal8

Darling Ingredients’ Health Brand Rousselot Receives U.S. Patent for Nextida® GC, the First Collagen Peptide Composition Supporting Blood Glucose Regulation

$DARPress releaseJun 3, 2026, 5:10 PM ETRead the release

Darling Ingredients’ health brand Rousselot received U.S. Patent No. US12636339 for Nextida GC, a collagen peptide composition designed to support healthy after-meal blood sugar levels. The patent protects both the production process and the use of the ingredient in dietary supplements, positioning it as a non-pharmaceutical option for glucose management.

Key figures

Patent number
US12636339
Global patents awarded
4
Patents pending countries
["Brazil","Canada","Colombia","Korea","Mexico","India","Peru"]

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.